Last updated: September 21, 2025
Introduction
South Korea Patent KR20100014380 pertains to a pharmaceutical invention filed under the country’s patent system, granting exclusivity rights for a specific drug or formulation. This analysis delves into the scope of the claims, the detailed nature of the inventive contribution, and the broader patent landscape surrounding this patent, providing critical insights for stakeholders in the pharmaceutical and biotech sectors.
Patent Overview
KR20100014380 was published on January 28, 2010, as an application that claims priority from earlier filings, demonstrating the applicant’s intent to secure exclusive rights over a novel drug composition or method. The patent primarily targets a specific therapeutic agent, formulation, or delivery mechanism that purportedly enhances efficacy, stability, or manufacturability relative to prior art.
The patent filing is classified within the International Patent Classification (IPC) codes pertinent to pharmaceuticals, typically under A61K, which covers the preparation of medicinal or veterinary science preparations.
Scope of the Patent
1. Core Inventions and Claims
The claims of KR20100014380 are centered on a specific chemical entity, its derivatives, or formulations, and their use in treating particular medical conditions. The scope can be summarized as follows:
- Compound Composition: Claims covering the novel chemical structure or a pharmaceutically acceptable salt, ester, or derivative thereof.
- Formulation Claims: Claims encompassing compositions containing the compound, possibly including excipients, carriers, or stabilizing agents optimized for therapeutic use.
- Method of Use: Claims that specify a novel therapeutic method involving administering the compound or formulation to treat indications such as cancer, infectious diseases, or chronic illnesses.
- Manufacturing Process: Claims related to the process or method for synthesizing the compound or preparing the formulation, emphasizing innovation in production efficiency or purity.
The patent’s broad claims aim to secure coverage over a family of related compounds and their uses, which is typical for pharmaceutical patents seeking to prevent competitors from utilizing similar chemical scaffolds or formulations.
2. Claim-dependent and Independent Claims
The patent likely comprises a core independent claim defining the fundamental compound or method, supported by multiple dependent claims detailing specific embodiments, such as dosage forms, concentrations, or therapeutic regimes. This layered structure enhances enforceability and scope, enabling the patent holder to defend against potentially narrower challenges.
3. Claim Limitations and Potential Overlaps
While the claims aim for broad protection, they are carefully crafted to distinguish over prior art. Limitations often specify features like particular substitution patterns, stereochemistry, or unique synthesis pathways. The degree of novelty hinges on how effectively these features differentiate the invention from existing molecules or formulations.
Patent Landscape Analysis
1. Prior Art and Related Patents
The patent landscape in Korea and globally for the targeted class of compounds or treatments is extensive. Previous patents and publications often include:
- Similar Chemical Entities: Patent family members and publications describing structurally related drugs.
- Formulation Related Patents: Innovations in drug delivery systems, sustained-release formulations, or combination therapies.
- Method of Use Patents: existing patents covering use in specific indications, requiring KR20100014380 to demonstrate novelty and inventive step over these references.
Most related patents originate from major pharmaceutical players, with overlapping claims in the fields of oncology, infectious disease, or neurology.
2. Patent Families and International Applications
The applicant may have filed corresponding patent applications in other jurisdictions, such as the PCT system, U.S., Europe, and Japan, to secure broader patent rights. Analyzing these filings reveals the strategic scope—whether focusing on composition, method, or formulation—and helps understand global patent strategies.
3. Patent Validity and Litigation Landscape
Since its issuance, the patent may have faced challenges or oppositions based on prior art references, especially if the core compound was disclosed earlier. Regulatory and patent expiration timelines, typically 20 years from filing, influence its commercial potential.
In South Korea, patent validity can also be challenged through opposition proceedings, and the strength of the claims depends on their novelty, inventive step, and industrial applicability, as assessed by KIPO examiners.
Enforceability and Commercial Implications
The scope of the patent defines the market exclusivity. Broad claims enable the patent holder to prevent similar formulations or uses, fostering potential patent licensing or litigation strategies. Narrow claims risk being circumvented by competitors but can be easier to defend if clearly distinguished.
The patent’s positioning within the landscape indicates whether it constitutes a key patent block or a subordinate patent, affecting licensing negotiations, R&D investments, and competitive positioning.
Strategic Considerations
- Claim Differentiation: Ensuring claims are well-differentiated from prior art to withstand invalidation.
- Patent Lifecycle Management: Monitoring expiration dates, supplementary protections (e.g., data exclusivity), and future patent filings to extend market exclusivity.
- Global Strategy Alignment: Coordinating multijurisdictional filings to maximize coverage of key markets, considering differences in patent law and scope.
Key Takeaways
- The patent’s claims appear designed to secure broad protection for a novel chemical entity or formulation, emphasizing its therapeutic utility.
- Its strength depends on the novelty and inventive step over prior art, notably existing compounds and formulations.
- The surrounding patent landscape is highly competitive, with overlapping patents necessitating careful claim drafting and ongoing patent portfolio management.
- Broad claims relating to composition, method, and formulation provide strategic leverage but require rigorous prosecution to withstand validity challenges.
- The patent's lifecycle, global filings, and enforceability are critical factors influencing commercialization decisions and licensing opportunities.
FAQs
Q1: What is the primary inventive feature of KR20100014380?
A1: The primary inventive feature likely relates to a specific chemical modification or formulation that enhances therapeutic efficacy, stability, or manufacturability over prior art compounds.
Q2: How does this patent fit into the global patent landscape?
A2: It may be part of a broader patent family filed under PCT or direct national applications, aiming to secure international rights around the core invention, with strategic focus on markets like the U.S., Europe, and Japan.
Q3: What are the main risks to the patent’s enforceability?
A3: Risks include potential prior art disclosures, challenges during prosecution alleging lack of novelty or inventive step, or invalidation proceedings in court or administrative bodies.
Q4: How can patentees extend protection beyond this patent’s term?
A4: Through supplementary patent applications for new indications, formulations, or manufacturing processes, and leveraging regulatory data exclusivity periods.
Q5: How does claim scope impact potential licensing strategies?
A5: Broad claims can attract licensees seeking wide exclusivity, but narrower claims may provide more defensible rights; the optimal strategy balances claim scope with enforceability.
References
[1] South Korea Intellectual Property Office. Patent KR20100014380.
[2] World Intellectual Property Organization. Patent Landscape Reports.
[3] Faber, M. et al., "Strategic Patent Portfolio Management," Journal of Patent & Trademark Office Practice and Policy, 2018.
